• León Felipe Ruiz-Arriaga, Ixchel Landgrave-Gómez, Sonia Toussaint-Caire, Rosa María Lacy-Niebla, and María Elisa Vega-Memije.
• Secretaría de Salud, Hospital General "Dr. Manuel Gea González", Departamento de Dermatología.
• Gac Med Mex. 2019 Jan 1; 155 (2): 130-135.

IntroductionCD30+ anaplastic large T cell lymphoma is a cutaneous primary lymphoma in which there is no evidence of systemic disease; histopathological study is required for its diagnosis.ObjectiveTo present the cases diagnosed with primary cutaneous CD30+ anaplastic large T-cell lymphoma over a 24-year period in Hospital General "Dr. Manuel Gea González" Department of Dermatology.MethodRetrospective study. Descriptive statistics was carried out. Information was collected on gender, age, clinical characteristics, complementary test results, previous and current treatments, histopathological studies reports and immunohistochemistry test results.ResultsOf 29 309 records, nine patients (0.000034%) with a diagnosis of CD30+ anaplastic T cell lymphoma were found. Histopathological and immunohistochemical diagnosis was confirmed by two certified dermatopathologists. Average age was 61.2 years, and there was a predominance of the female gender, with initial clinical presentation as a papular or nodular lesion and varied topography.ConclusionsThe prognosis of CD30+ anaplastic large T cell lymphoma in the studied population was dependent on clinical stage. The treatment at early stages has favorable results.Copyright: © 2019 SecretarÍa de Salud.

20 keywords...

hide…